ArticleActa pharmaceutica Sinica. B2025

DNAzyme targeting RIP3 suppresses NLRP3-mediated necroinflammation for the treatment of inflammatory diseases.

Jiaxin Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.